Immunoinformatics Study on Early 4 Protein of Human Papillomavirus Type 16 for Cervical Cancer Vaccine Peptide Candidate

Yani Suryani, Opik Taupiqurrohman, Muhammad Yusuf, Toto Subroto, Sukma Nuswantara

Abstract


 The aims of this study were to carry out testing of the early 4 protein of type 16 HPV through immunoinformatics meth-ods in an effort to get the peptide vaccine candidate for cervical cancer. The software used are IEDB-AR, CABSdock and Accelrys Discovery Study 4.5. Based on the analysis that sequence of ami-no acid lysine, leucine, leucine, glycine, serine, threonine, tryp-tophan, proline and threonine (KLLGSTWPT) and the sequence of amino acid tyrosine, tyrosine, valine, leucine, histidine, leucine, cysteine, leucine, alanine, alanine, threonine, lysine, tyrosine, pro-line and leucine (YYVLHLCLAATKYPL) are peptide vaccine can-didate for cervical cancer from the early 4 protein of HPV type 16 


Keywords


cervical cancer, Early 4, Human papillomavirus, immunoinformatics, vaccine

Full Text:

PDF

References


Bellone M. (2005). Autoimmune Disease: Pathogenesis. Italy: John Wiley & Sons (http://www.els.net).

Blaszczyk, M., Mateusz, K., Maksim, K., Lukasz, W., Aleksander, D. & Andrzej K. (2016). Modeling of Protein-Pep-tide Interactions Using The CABS-dock Web Server for Binding Site Search and Flexible Docking. Method. 93, 72-83.

Bruni, L., Albero, G., Serrano, B., Mena, M., Gómez, D., Muñoz, J., Bosch, FX. & de Sanjosé, S. (2019). ICO/IARC Informa

tion Centre on HPV and Cancer (HPV Information Centre). Summary Report. Human Papillomavirus and Related Diseases in Indonesia.

Fatima, S. S. & Desu, J. (2014). Proteome Analysis and Antigenic Peptide Predic-tion of Beta Corona Cirus, A Cause of MERS. Helix, (5), 590-583.

Fleri, W. (2012). T-Cell epitopes - MHC Class I Binding Prediction Tools Description. Retrieved from http://help.iedb.org/ entries/21903572-t-cell-epitopes-mhc-class-ii-binding-prediction-tools-de-scription.

Fleri, W. (2012). T-Cell epitopes - MHC Class II Binding Prediction Tools Description IEDB Solutions Center. Retrieved from http://help.iedb.org/entries/21903572-t-cell-epitopes-mhc-class-i-binding-pre-diction-tools-description.

Gonzalez, A. D., Marcela, L., Myrna, C., Lucely, C., Claudia, A. & Eduardo, C. (2005). Epigenetics of Cervical Cancer. An Overview and Therapeutic Perspec-tives. Molecular Cancer, 4(38), 1-24.

Kim, Y., Julia, P., Zhanyang, Z., Dorjee, T., Peng, W. & Jason, G. (2012). Immune Epitope Database Analysis Resource. Nucleic Acids Research, 40, 525-530.

Kurcinski, M., Michal, J., Maciej, B., Andrzej, K. & Sebastian, K. (2015). CABS-Dock Web Server for the Flexible Docking of Peptides to Proteins without Prior Knowledge of the Binding Site. Nucleic Acids Research, 1-6.

Li, B., Xianfang, Z., Chuancui, H. & Yunx-ia, C. (2015). Human papillomavirus Genome-Wide Identification of T-cell Epitopes for Peptide Vaccine Develop-ment Against Cervical Cancer: An Inte-gration of Computational Analysis and Experimental Assay. J Computation Biol, 22(10), 962–974.

Morshed, K., Dorota, P., Marcin, S. & Małgor-zata, P. (2014). Human Papillomavirus (HPV) – Structure, Epidemiology and Pathogenesis. Otolaryngology Polska. Elsevier. pp. 213 – 219

Sompayrac, L. How the Immune System Work. 3ed Edition. (2008). Massachussetts: Well Publishing.

Taupiqurrohman, O. (2016). Desain dan Pengembangan Vaksin Human Papillo-mavirus Tipe 16 Berbasis Epitop Secara In Silico. Thesis. Bandung. Universitas Padjadjaran

Taupiqurrohman, O., Yusuf, M., S. Nuswan-tara, T. & Subroto, T. (2016). Potensi Gen Oncoprotein Human Papillomavi-rus Tipe 16 Sebagai Kandidat Vaksin Kanker Serviks. MKB, 48(35), 84– 91.

Vita, R., Laura, Z., Jason, A. G., Hussein, E., Ilka, H., Nima & Rohini D. (2010). The immune Epitope Database 2.0. Nucleic Acid Research, 38, 854-862.

WHO. (2019). Human papillomavirus (HPV) and cervical cancer. [Downloaded at Agustus 2019]. https://www.who.int/ news-room/fact-sheets/detail/human-pap-illomavirus-(hpv)-and-cervical-cancer




DOI: https://doi.org/10.15575/biodjati.v4i2.5414

Refbacks

  • There are currently no refbacks.


Indexing By :

      

      

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

 

View My Stats